Vanguard Group’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$136K Buy
2022
Q2
$110K Sell
2022
Q1
$218K Sell
2021
Q4
$1.68M Sell
2021
Q3
$3.35M Buy
2021
Q2
$3.18M Sell
2021
Q1
$5.82M Buy
2020
Q4
$6.01M Buy
2020
Q3
$3.03M Sell
2020
Q2
$2.84M Buy
2020
Q1
$1.57M Buy
2019
Q4
$2.28M Sell
2019
Q3
$3.44M Buy
2019
Q2
$3.61M Buy
2019
Q1
$2.67M Buy
2018
Q4
$2.25M Buy